Effects of lysosomal protease inhibitors on the degradation of acetylated low density lipoprotein in cultured rat peritoneal macrophages

J Atheroscler Thromb. 1994;1(1):41-4. doi: 10.5551/jat1994.1.41.

Abstract

The effect of protease inhibitors, leupeptin and pepstatin A, on the metabolism of acetylated low density lipoprotein (acetyl-LDL) was investigated in cultured rat peritoneal macrophages and compared with that of chloroquine. While both leupeptin and pepstatin inhibited the proteolytic degradation of 125I-acetyl-LDL, a combination of both showed an additive effect. Similar to chloroquine, both protease inhibitors diminished [3H] oleate incorporation into cellular cholesteryl[3H] oleate and increased cholesterol content of macrophages. These results suggest that both thiol protease and cathepsin D participate in the physiological degradation of apolipoprotein in macrophages. The inhibition of apolipoprotein degradation seemed to have an effect on cholesterol metabolism in macrophages cultured with acetyl-LDL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Cells, Cultured
  • Cholesterol / metabolism
  • Humans
  • Iodine Radioisotopes
  • Leupeptins / pharmacology*
  • Lipoproteins, LDL / drug effects*
  • Lipoproteins, LDL / metabolism
  • Lysosomes / drug effects*
  • Lysosomes / metabolism
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / metabolism
  • Oleic Acid / metabolism
  • Pepstatins / pharmacology*
  • Protease Inhibitors / pharmacology*
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Tritium

Substances

  • Iodine Radioisotopes
  • Leupeptins
  • Lipoproteins, LDL
  • Pepstatins
  • Protease Inhibitors
  • Tritium
  • Streptomyces pepsin inhibitor
  • Oleic Acid
  • Cholesterol
  • leupeptin
  • pepstatin